CCM
MEDP icon

Channing Capital Management’s Medpace MEDP Stock Holding History

Channing Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-110,897
Closed -$44.8M – 110
2024
Q1 		$44.8M Sell
110,897
-54,664
-33% -$19.2M 1.2% 42
2023
Q4 		$50.7M Buy
165,561
+52
+0% +$14K 1.5% 38
2023
Q3 		$40.1M Sell
165,509
-70,457
-30% -$18M 1.32% 41
2023
Q2 		$56.7M Buy
235,966
+338
+0.1% +$70.2K 1.74% 25
2023
Q1 		$44.3M Sell
235,628
-11,100
-4% -$2.3M 1.43% 38
2022
Q4 		$52.4M Buy
246,728
+15,268
+7% +$3.05M 1.67% 28
2022
Q3 		$36.4M Buy
231,460
+72,149
+45% +$11.5M 1.26% 40
2022
Q2 		$23.8M Buy
+159,311
New +$23.1M 0.78% 40

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Channing Capital Management's MEDP Position: Q2 2024 in Review

Channing Capital Management sold out of Medpace (MEDP) in Q2 2024, closing a stake of 110,897 shares — an estimated $44.8M sold.

Channing Capital Management first reported a position in MEDP in Q2 2022 and held it in 8 quarters. The position peaked at $56.7M in Q2 2023. 623 funds tracked by Wall St. Rank hold MEDP as of Q2 2024.

  • Channing Capital Management reported no remaining Medpace position as of Q2 2024 after selling out during the quarter.
  • Channing Capital Management sold 110,897 Medpace shares in Q2 2024, an estimated $44.8M.
  • Channing Capital Management first reported a position in Medpace in Q2 2022 and held it in 8 quarters.
  • Channing Capital Management's Medpace position peaked at $56.7M in Q2 2023.
  • 623 funds tracked by Wall St. Rank held Medpace as of Q2 2024.

Based on Channing Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.